License Agreements - Narrative (Details) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
|
Dec. 20, 2024
USD ($)
|
Dec. 19, 2024
USD ($)
d
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
|
| Capitalized Contract Cost [Line Items] | ||||||
| Royalties on net product sales | $ 0 | $ 0 | $ 0 | $ 500,000 | ||
| BMS License Agreement | ||||||
| Capitalized Contract Cost [Line Items] | ||||||
| Payments related to milestone | $ 0 | $ 0 | $ 0 | $ 0 | ||
| WuXi Biologics License Agreement | ||||||
| Capitalized Contract Cost [Line Items] | ||||||
| Non-refundable partial upfront payment | $ 6,000,000 | |||||
| Additional non-refundable upfront payment | $ 38,000,000 | |||||
| Number of days due with in effective date of license agreement | d | 120 | |||||
| Aggregate payment of achievement of certain development milestone | $ 265,000,000 | |||||
| Aggregate payment of achievement of certain commercial milestone | $ 540,000,000 | |||||
| License agreement term | 10 years | |||||